Context-Aware Follow-Up Optimization for Type 2 Diabetes
A study uses a Contextual Markov Decision Process to optimize follow-up intervals for Type 2 Diabetes patients based on EHR data from 22,154 patients. The model identifies two clinical contexts—low and high risk—and recommends adaptive intervals: 1 month for unmeasured lab values, up to 3 months for elevated values or hospitalizations, and 6–12 months for stable control, with shorter intervals for high-risk patients. The CMDP policies reduced expected cumulative costs by 34.8% in high-comorbidity and 6.4% in low-comorbidity contexts compared to a fixed interval policy.